Shanghai Rendu (China) Today
| 688193 Stock | 42.49 0.11 0.26% |
Performance17 of 100
| Odds Of DistressLess than 49
|
Shanghai Rendu is trading at 42.49 as of the 3rd of December 2024, a 0.26% up since the beginning of the trading day. The stock's open price was 42.38. Shanghai Rendu has 49 percent odds of going through some form of financial distress in the next two years but had a very solid returns during the last 90 days. Equity ratings for Shanghai Rendu Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Shanghai Rendu is entity of China. It is traded as Stock on SHG exchange. The company has 40 M outstanding shares. More on Shanghai Rendu Biotechnology
Moving together with Shanghai Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shanghai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shanghai Rendu's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shanghai Rendu or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Biotech (View all Themes) |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Shanghai Rendu Biotechnology (688193) is traded on Shanghai Stock Exchange in China and employs 358 people. Shanghai Rendu is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai Rendu's market, we take the total number of its shares issued and multiply it by Shanghai Rendu's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai Rendu Biote operates under Biotechnology sector and is part of Health Care industry. The entity has 40 M outstanding shares.
Shanghai Rendu generates positive cash flow from operations, but has no cash available
Check Shanghai Rendu Probability Of Bankruptcy
Ownership AllocationShanghai Rendu maintains a total of 40 Million outstanding shares. Shanghai Rendu Biote has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.13 % of Shanghai Rendu outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Shanghai Ownership Details
Shanghai Rendu Biote Risk Profiles
Although Shanghai Rendu's alpha and beta are two of the key measurements used to evaluate Shanghai Rendu's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.95 | |||
| Semi Deviation | 3.15 | |||
| Standard Deviation | 4.61 | |||
| Variance | 21.25 |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Rendu without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Shanghai Rendu Corporate Executives
Elected by the shareholders, the Shanghai Rendu's board of directors comprises two types of representatives: Shanghai Rendu inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Rendu's management team and ensure that shareholders' interests are well served. Shanghai Rendu's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Rendu's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tingjiang Cai | CFO Supervisor | Profile |
Other Information on Investing in Shanghai Stock
Shanghai Rendu financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Rendu security.